Is There an Increased Risk of GERD After Helicobacter pylori Eradication?: A Meta-Analysis
- 1 May 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 105 (5), 1007-1013
- https://doi.org/10.1038/ajg.2009.734
Abstract
Some studies suggest that eradication of Helicobacter pylori (Hp) might increase the risk of gastroesophageal reflux disease (GERD) in a portion of patients. We aimed to conduct a meta-analysis to investigate this. A comprehensive, English, multiple-source literature search was performed from 1983 to February 2007. Only randomized controlled trial (RCT) and cohort studies comparing the prevalence of GERD in patients free from GERD at baseline with Hp eradication vs. those with persistent Hp were included. Quality of RCTs and cohorts was assessed by Jadad and New Castle-Ottawa scores, respectively. Meta-analysis of pooled odds ratios (ORs) was performed using Review Manager 4.2.10. Twelve (7 RCTs and 5 cohorts) of 271 articles were included. In six RCTs using erosive GERD as outcome, the OR for the frequency of GERD in Hp eradicated group vs. persistent Hp group was 1.11 (0.81–1.53, P=0.52). In five RCTs using symptomatic outcome, the OR for the frequency of GERD in Hp eradicated group vs. persistent Hp was 1.22 (0.89–1.69, P=0.22). In cohort studies, the OR for the frequency of GERD in Hp eradicated group vs. persistent Hp was 1.37 (0.89–2.12; P=0.15). Test of heterogeneity was not significant for any analyses. The results were consistent in subgroup and sensitivity analyses, including cohort studies vs. RCTs, high-quality studies vs. low-quality studies, and use of endoscopic vs. symptomatic outcomes except for the subgroup of patients with peptic ulcer disease (PUD) in cohort studies (OR: 2.04 (1.08–3.85); P=0.03). There is no association between Hp eradication and development of new cases of GERD in the population of dyspeptic patients. However, in cohort studies, there seems to be a twofold higher risk of development of erosive GERD in patients with PUD. The effect in RCTs of patients with PUD did not show a significant difference.Keywords
This publication has 27 references indexed in Scilit:
- Full publication of results initially presented in abstractsCochrane Database of Systematic Reviews, 2007
- Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patientsPublished by Wiley ,2006
- Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trialAlimentary Pharmacology & Therapeutics, 2005
- Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their resultsCMAJ : Canadian Medical Association Journal, 2005
- Review article: Helicobacter pylori and gastro‐oesophageal reflux disease − the European perspectiveAlimentary Pharmacology & Therapeutics, 2004
- The effect of Helicobacter pylori and its eradication on gastro‐oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitisAlimentary Pharmacology & Therapeutics, 2004
- Reflux esophagitis after eradication of Helicobacter pylori is associated with the degree of hiatal herniaScandinavian Journal of Gastroenterology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - results from a randomized trial programmeAlimentary Pharmacology & Therapeutics, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996